Literature DB >> 563883

Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects.

R K Bush, W Busse, D Flaherty, D Warshauer, E C Dick, C E Reed.   

Abstract

We infected 7 normal volunteers with rhinovirus 16. In general, the symptoms and alterations in airways were minimal although all subjects had upper respiratory symptoms. Three subjects developed in addition lower respiratory and systemic symptoms accompanied by either an increase in the volume of isoflow or a positive methacholine response. Furthermore, these three had a decrease in beta adrenergic and H2 histamine receptor responses of their granulocytes. Since the peripheral airway obstruction and decreased beta adrenergic and H2 histamine responses occurred together, these two phenomenon may have a common cause. All seven subjects had a decrease in number of circulating E rosette-forming lymphocytes, and in 6 of 7, there was a decrease in the antibody-dependent cellular cytotoxicity capacity of mononuclear cell preparations. It is not clear whether these changes reflect redistribution of mononuclear cells or alteration of their function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 563883     DOI: 10.1016/0091-6749(78)90229-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.

Authors:  R F Lemanske; E C Dick; C A Swenson; R F Vrtis; W W Busse
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface.

Authors:  W Wang; W M Lee; A G Mosser; R R Rueckert
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Effects of infectious bovine rhinotracheitis virus infection on bovine airway reactivity.

Authors:  P D Conlon; P O Ogunbiyi; R J Perron; P Eyre
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

4.  Effect of inhibition of prostaglandin synthesis on induced bronchial hyperresponsiveness.

Authors:  E H Walters
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

5.  Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.

Authors:  Wai-Ming Lee; Wensheng Wang
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group.

Authors:  W M Lee; W Wang; R R Rueckert
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

7.  PROPHYLACTIC ANTIBODY TREATMENT AND INTRAMUSCULAR IMMUNIZATION REDUCE INFECTIOUS HUMAN RHINOVIRUS 16 LOAD IN THE LOWER RESPIRATORY TRACT OF CHALLENGED COTTON RATS.

Authors:  Jorge C G Blanco; Susan Core; Lioubov M Pletneva; Thomas H March; Marina S Boukhvalova; Adriana E Kajon
Journal:  Trials Vaccinol       Date:  2014

Review 8.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

9.  Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to β-adrenoceptor agonists in mouse lung.

Authors:  Chantal Donovan; Huei Jiunn Seow; Jane E Bourke; Ross Vlahos
Journal:  Clin Sci (Lond)       Date:  2016-04-10       Impact factor: 6.124

10.  Influence of age, sex and respiratory viruses on the rates of emergency department visits and hospitalisations with respiratory tract infections, asthma and COPD.

Authors:  Imran Satia; Adil Adatia; Ruth P Cusack; Justina M Greene; Paul M O'Byrne; Kieran J Killian; Neil Johnston
Journal:  ERJ Open Res       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.